Company
Members
Christina Marie Coughlin
이사/ Board of Director
- Education/Major
- M.D. and Ph.D. in Medicine and Immunology, University of Pennsylvania
- Major carreer
- CEO of Avacta (Present)
- Chief Executive Officer, CytoImmune Therapeutics
- Chief Medical Officer, Rubius Therapeutics (led clinical development and regulatory efforts for allogeneic red cell therapy platform)
- Chief Medical Officer, Tmunity Therapeutics (developed autologous CAR-T and TCR-T therapies)
- Chief Medical Officer, Immunocore (led development of Kimmtrak™ for metastatic uveal melanoma)
- Leadership roles at Pfizer (Oncology Asset Team Leader) and Novartis (Clinical Program Team Lead)